Cargando…

Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study

INTRODUCTION: The established neuroprotective property of the sex steroid precursor dehydroepiandrosterone-sulfate (DHEAS) has not yet been investigated in the context of aneurysmal subarachnoid hemorrhage (aSAH). The influence of DHEAS on inflammatory response resulting in modulation of interleukin...

Descripción completa

Detalles Bibliográficos
Autores principales: Höllig, Anke, Thiel, Miriam, Stoffel-Wagner, Birgit, Coburn, Mark, Clusmann, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462180/
https://www.ncbi.nlm.nih.gov/pubmed/25993987
http://dx.doi.org/10.1186/s13054-015-0954-1
_version_ 1782375627339333632
author Höllig, Anke
Thiel, Miriam
Stoffel-Wagner, Birgit
Coburn, Mark
Clusmann, Hans
author_facet Höllig, Anke
Thiel, Miriam
Stoffel-Wagner, Birgit
Coburn, Mark
Clusmann, Hans
author_sort Höllig, Anke
collection PubMed
description INTRODUCTION: The established neuroprotective property of the sex steroid precursor dehydroepiandrosterone-sulfate (DHEAS) has not yet been investigated in the context of aneurysmal subarachnoid hemorrhage (aSAH). The influence of DHEAS on inflammatory response resulting in modulation of interleukin 6 (IL-6) synthesis has been shown. Here, we evaluate DHEAS serum levels after aSAH (day 0–14) and levels of IL-6 related to functional outcome at discharge and at six months. METHODS: A complete data set (DHEAS and IL-6 serum levels for days 0, 1, 4, 7, 10 and 14 after aSAH) and outcome assessment at discharge according to modified Rankin Scale score (mRS) was available for 53 patients of the initially screened cohort (n = 109). Outcome assessment six months after aSAH was obtained from 41 patients. Logarithmized levels of DHEAS and IL-6 were related to dichotomized functional outcome either assessed at discharge or at six months. A mixed between-within subjects ANOVA was applied for statistical analysis (SPSS 21.0). RESULTS: DHEAS and IL-6 levels across time were related to functional outcome. Regarding outcome assessment at discharge and at six months after aSAH, DHEAS levels (transformed to square root for statistical purposes) were considerably higher in patients with favorable outcome (mRS 0–2) (p = .001; p = .020). Inversely, in patients with favorable outcome either at discharge or six months after aSAH, lower IL-6 levels (logarithmized for statistical purposes) were observed across time (both p < .001). CONCLUSION: We provide new evidence that DHEAS is associated with protective properties resulting in improvement of functional outcome after aSAH, possibly by influencing the inflammatory response after aSAH shown in the decreasing IL-6 serum levels. But the results for outcome six months after SAH are limited due to a high drop-out rate. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-0954-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4462180
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44621802015-06-11 Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study Höllig, Anke Thiel, Miriam Stoffel-Wagner, Birgit Coburn, Mark Clusmann, Hans Crit Care Research INTRODUCTION: The established neuroprotective property of the sex steroid precursor dehydroepiandrosterone-sulfate (DHEAS) has not yet been investigated in the context of aneurysmal subarachnoid hemorrhage (aSAH). The influence of DHEAS on inflammatory response resulting in modulation of interleukin 6 (IL-6) synthesis has been shown. Here, we evaluate DHEAS serum levels after aSAH (day 0–14) and levels of IL-6 related to functional outcome at discharge and at six months. METHODS: A complete data set (DHEAS and IL-6 serum levels for days 0, 1, 4, 7, 10 and 14 after aSAH) and outcome assessment at discharge according to modified Rankin Scale score (mRS) was available for 53 patients of the initially screened cohort (n = 109). Outcome assessment six months after aSAH was obtained from 41 patients. Logarithmized levels of DHEAS and IL-6 were related to dichotomized functional outcome either assessed at discharge or at six months. A mixed between-within subjects ANOVA was applied for statistical analysis (SPSS 21.0). RESULTS: DHEAS and IL-6 levels across time were related to functional outcome. Regarding outcome assessment at discharge and at six months after aSAH, DHEAS levels (transformed to square root for statistical purposes) were considerably higher in patients with favorable outcome (mRS 0–2) (p = .001; p = .020). Inversely, in patients with favorable outcome either at discharge or six months after aSAH, lower IL-6 levels (logarithmized for statistical purposes) were observed across time (both p < .001). CONCLUSION: We provide new evidence that DHEAS is associated with protective properties resulting in improvement of functional outcome after aSAH, possibly by influencing the inflammatory response after aSAH shown in the decreasing IL-6 serum levels. But the results for outcome six months after SAH are limited due to a high drop-out rate. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-015-0954-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-05-21 2015 /pmc/articles/PMC4462180/ /pubmed/25993987 http://dx.doi.org/10.1186/s13054-015-0954-1 Text en © Höllig et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Höllig, Anke
Thiel, Miriam
Stoffel-Wagner, Birgit
Coburn, Mark
Clusmann, Hans
Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title_full Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title_fullStr Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title_full_unstemmed Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title_short Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
title_sort neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462180/
https://www.ncbi.nlm.nih.gov/pubmed/25993987
http://dx.doi.org/10.1186/s13054-015-0954-1
work_keys_str_mv AT holliganke neuroprotectivepropertiesofdehydroepiandrosteronesulfateanditsrelationshiptointerleukin6afteraneurysmalsubarachnoidhemorrhageaprospectivecohortstudy
AT thielmiriam neuroprotectivepropertiesofdehydroepiandrosteronesulfateanditsrelationshiptointerleukin6afteraneurysmalsubarachnoidhemorrhageaprospectivecohortstudy
AT stoffelwagnerbirgit neuroprotectivepropertiesofdehydroepiandrosteronesulfateanditsrelationshiptointerleukin6afteraneurysmalsubarachnoidhemorrhageaprospectivecohortstudy
AT coburnmark neuroprotectivepropertiesofdehydroepiandrosteronesulfateanditsrelationshiptointerleukin6afteraneurysmalsubarachnoidhemorrhageaprospectivecohortstudy
AT clusmannhans neuroprotectivepropertiesofdehydroepiandrosteronesulfateanditsrelationshiptointerleukin6afteraneurysmalsubarachnoidhemorrhageaprospectivecohortstudy